ClinicalTrials.gov
ClinicalTrials.gov Menu

CHOP-Rituximab Augmented With GM-CSF in Patients With Previously Untreated Diffuse Large B Cell Non-Hodgkin's Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00455897
Recruitment Status : Terminated (Accrual was too slow. Trial terminated)
First Posted : April 4, 2007
Last Update Posted : January 18, 2018
Sponsor:
Collaborators:
Beth Israel Deaconess Medical Center
Brigham and Women's Hospital
Dana-Farber Cancer Institute
Bayer
Information provided by (Responsible Party):
Ephraim Hochberg, MD, Massachusetts General Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : November 2007
  Actual Study Completion Date : July 2011